Angiography of Retinal Vascular Diseases

  • Lihteh Wu
  • Andrea Porras
  • Raquel Benavides
  • David G. Zeballos
  • J. Fernando Arevalo

The optical properties of the eye make the ocular fundus the only location in the human body where direct noninvasive monitoring of vascular flow is possible. During fluorescein angiography (FA) and indocyanine green videoangiography (ICGV), a rapid sequence of serial photographs taken after the intravenous administration of fluorescein or indocyanine green (ICG) is used to visualize and document choroidal and retinal blood flow. Other than blood flow, FA and ICGV provide information about the integrity of the blood-retinal barriers and the fine details of the retinal pigment epithelium (RPE), and provide a glimpse of associated systemic pathology. Although both technologies reveal important and different aspects of retinal and choroidal diseases, some phases of various diseases are best seen with FA and other aspects are best revealed with ICGV.


Diabetic Retinopathy Macular Edema Diabetic Macular Edema Retinal Vein Occlusion Vitreous Hemorrhage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987;27:230–238.PubMedGoogle Scholar
  2. 2.
    Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237–243.PubMedGoogle Scholar
  3. 3.
    The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977–986.Google Scholar
  4. 4.
    Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297–303.PubMedGoogle Scholar
  5. 5.
    Wolfensberger TJ. The historical discovery of macular edema. Doc Ophthalmol 1999;97:207–216.PubMedGoogle Scholar
  6. 6.
    Duke-Elder S, Dobree JH. Diseases of the retina. In: DukeElder S, ed. System of ophthalmology, vol X. St. Louis: CV Mosby, 1967:410.Google Scholar
  7. 7.
    Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464–1474.PubMedGoogle Scholar
  8. 8.
    Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801–1815.PubMedGoogle Scholar
  9. 9.
    Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7–16.PubMedGoogle Scholar
  10. 10.
    Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol 1999;14:233–239.PubMedGoogle Scholar
  11. 11.
    Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99–109.PubMedGoogle Scholar
  12. 12.
    Kristinsson JK, Gottfredsdottir MS, Stefansson E. Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 1997;81:274–278.PubMedGoogle Scholar
  13. 13.
    Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 2002;47(suppl 2):S263–S269.PubMedGoogle Scholar
  14. 14.
    Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487.PubMedGoogle Scholar
  15. 15.
    Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbeil JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content: vascular endothelial growth factor decreases occluding in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953–1959.PubMedGoogle Scholar
  16. 16.
    Wilkinson CP, Ferris FL III, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;l10:1677–1682.PubMedGoogle Scholar
  17. 17.
    Lewis H. The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 2001;131:123–125.PubMedGoogle Scholar
  18. 18.
    Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL III. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134–1139.PubMedGoogle Scholar
  19. 19.
    Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019–1029.PubMedGoogle Scholar
  20. 20.
    Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82–106.Google Scholar
  21. 21.
    Berger AR, Boniuk I. Bilateral subretinal neovascularization after focal argon laser photocoagulation for diabetic macular edema. Am J Ophthalmol 1989;108:88–90.PubMedGoogle Scholar
  22. 22.
    Lewis H, Schachat AP, Haimann MH, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990;97:503–510; discussion 510–511.PubMedGoogle Scholar
  23. 23.
    Shah GK. Photodynamic therapy for choroidal neovascularization after thermal laser photocoagulation for diabetic macular edema. Am J Ophthalmol 2003;135:114–116.PubMedGoogle Scholar
  24. 24.
    Kychenthal A, Siebert A, Dorta P, Aylward B. Surgical removal of a laser-induced choroidal neovascular membrane. Retina 2001;21:69–71.PubMedGoogle Scholar
  25. 25.
    Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD. Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1997;115:873–877.PubMedGoogle Scholar
  26. 26.
    Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309–315.PubMedGoogle Scholar
  27. 27.
    Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–927.PubMedGoogle Scholar
  28. 28.
    Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57–61.PubMedGoogle Scholar
  29. 29.
    Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24–27.PubMedGoogle Scholar
  30. 30.
    Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279–1282.PubMedGoogle Scholar
  31. 31.
    Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791–796.PubMedGoogle Scholar
  32. 32.
    Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114:743–750.PubMedGoogle Scholar
  33. 33.
    Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. Arch Ophthalmol 1985;103:1644–1652.Google Scholar
  34. 34.
    Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258–260.PubMedGoogle Scholar
  35. 35.
    Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976;81:383–396.Google Scholar
  36. 36.
    Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79:371–422.PubMedGoogle Scholar
  37. 37.
    Orth DH, Patz A. Retinal branch vein occlusion. Surv Ophthalmol 1978;22:357–376.PubMedGoogle Scholar
  38. 38.
    Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992;99:509–514.PubMedGoogle Scholar
  39. 39.
    Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1996;114:545–554.Google Scholar
  40. 40.
    Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998;105:412–416.PubMedGoogle Scholar
  41. 41.
    Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488–506.PubMedGoogle Scholar
  42. 42.
    McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 1995;113:456–462.PubMedGoogle Scholar
  43. 43.
    McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219–229.PubMedGoogle Scholar
  44. 44.
    McAllister IL, Vijayasekaran S, Yu DY, Constable IJ. Chorioretinal venous anastomoses: effect of different laser methods and energy in human eyes without vein occlusion. Graefes Arch Clin Exp Ophthalmol 1998;236:174–181.PubMedGoogle Scholar
  45. 45.
    Browning DJ, Rotberg MH. Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996;122:588–589.PubMedGoogle Scholar
  46. 46.
    Ip M, Kahana A, Altaweel M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 2003;18:67–73.PubMedGoogle Scholar
  47. 47.
    Arciniegas A. Treatment of the occlusion of the central retinal vein by section of the posterior ring. Ann Ophthalmol 1984;16:1081–1086.PubMedGoogle Scholar
  48. 48.
    Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408–415.PubMedGoogle Scholar
  49. 49.
    Garciia-Arumii J, Boixadera A, Martinez-Castillo V, Castillo R, Dou A, Corcostegui B. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 2003;121:1385–1391.PubMedGoogle Scholar
  50. 50.
    Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219–221; discussion 222–223.PubMedGoogle Scholar
  51. 51.
    Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 2003;135:382–384.PubMedGoogle Scholar
  52. 52.
    Kimmel AS, McCarthy MJ, Blodi CF, Folk JC. Branch retinal vein occlusion in sarcoidosis. Am J Ophthalmol 1989;107:561–562.PubMedGoogle Scholar
  53. 53.
    Friberg TR. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Case report. Arch Ophthalmol 1988;106:585–586.PubMedGoogle Scholar
  54. 54.
    Tekeli O, Gursel E, Buyurgan H. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 1999;77:628–630.PubMedGoogle Scholar
  55. 55.
    Glacet-Bernard A, Bayani N, Chretien P, Cochard C, Lelong F, Coscas G. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol 1994;112:790–795.PubMedGoogle Scholar
  56. 56.
    Staurenghi G, Lonati C, Aschero M, Orzalesi N. Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am J Ophthalmol 1994;117:211–213.PubMedGoogle Scholar
  57. 57.
    Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol 1990;109:298–302.PubMedGoogle Scholar
  58. 58.
    Spaide RF, Lee JK, Klancnik JK Jr, Gross NE. Optical coherence tomography of branch retinal vein occlusion. Retina 2003;23:343–347.PubMedGoogle Scholar
  59. 59.
    Harino S, Oshima Y, Tsujikawa K, Ogawa K, Grunwald JE. Indocyanine green and fluorescein hyperfluorescence at the site of occlusion in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:18–24.PubMedGoogle Scholar
  60. 60.
    Panozzo G, Gusson E, Parolini B, Mercanti A. Role of OCT in the diagnosis and follow up of diabetic macular edema. Semin Ophthalmol 2003;18:74–81.PubMedGoogle Scholar
  61. 61.
    Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984;98:271–282.Google Scholar
  62. 62.
    Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154–155.PubMedGoogle Scholar
  63. 63.
    Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 1986;104:34–41.Google Scholar
  64. 64.
    McAllister IL, Yu DY, Vijayasekaran S, Barry C, Constable I. Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion. Br J Ophthalmol 1992;76:615–620.PubMedGoogle Scholar
  65. 65.
    Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 1988;11:239–251.PubMedGoogle Scholar
  66. 66.
    Kearns TP, Hollenhorst RW. Venous-stasis retinopathy of occlusive disease of the carotid artery. Mayo Clin Proc 1963;38:304–312.Google Scholar
  67. 67.
    MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1991;337:1235–1243.Google Scholar
  68. 68.
    Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445–453.Google Scholar
  69. 69.
    von Graefe A. Ueber Embolie der arteria centralis retinae als Urscahe plotzlicher Erblingdung. Arch fur Ophthalmol 1859;5:136–157.Google Scholar
  70. 70.
    Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology 1982;89:14–19.PubMedGoogle Scholar
  71. 71.
    Wilson LA, Warlow CP, Russell RW. Cardiovascular disease in patients with retinal arterial occlusion. Lancet 1979;l:292–294.PubMedGoogle Scholar
  72. 72.
    Sharma S, Naqvi A, Sharma SM, Cruess AF, Brown GC. Transthoracic echocardiographic findings in patients with acute retinal arterial obstruction. A retrospective review. Retinal Emboli of Cardiac Origin Group. Arch Ophthalmol 1996;114:1189–1192.PubMedGoogle Scholar
  73. 73.
    Mohan K, Gupta A, Jain IS, Banerjee CK. Bilateral central retinal artery occlusion in occult temporal arteritis. J Clin Neuroophthalmol 1989;9:270–272.PubMedGoogle Scholar
  74. 74.
    Duker JS, Brown GC. Neovascularization of the optic disc associated with obstruction of the central retinal artery. Ophthalmology 1989;96:87–91.PubMedGoogle Scholar
  75. 75.
    Marmor MF, Jampol LM, Wohl L. Cilioretinal collateral circulation after occlusion of the central retinal artery. Br J Ophthalmol 1985;69:805–809.PubMedGoogle Scholar
  76. 76.
    Shah GK, Sharma S, Brown GC. Iris neovascularization following branch retinal artery occlusion. Can J Ophthalmol 1998;33:389–390.PubMedGoogle Scholar
  77. 77.
    Brown GC, Duker JS, Lehman R, Eagle RC Jr. Combined central retinal artery-central vein obstruction. Int Ophthalmol 1993;17:9–17.PubMedGoogle Scholar
  78. 78.
    Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000;84:914–916.PubMedGoogle Scholar
  79. 79.
    Reynard M, Hanscom TA. Neodymium:yttrium-aluminumgarnet laser arteriotomy with embolectomy for central retinal artery occlusion. Am J Ophthalmol 2004;137:196–198.PubMedGoogle Scholar
  80. 80.
    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.PubMedGoogle Scholar
  81. 81.
    de Venecia G, Jampol LM. The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients. Arch Ophthalmol 1984;102:68–73.PubMedGoogle Scholar
  82. 82.
    Robertson DM. Macroaneurysms of the retinal arteries. Trans Am Acad Ophthalmol Otolaryngol 1973;77:OP55–O67.PubMedGoogle Scholar
  83. 83.
    Rabb MF, Gagliano DA, Teske MP. Retinal arterial macroaneurysms. Surv Ophthalmol 1988;33:73–96.PubMedGoogle Scholar
  84. 84.
    Nadel AJ, Gupta KK. Macroaneurysms of the retinal arteries. Arch Ophthalmol 1976;94:1092–1096.PubMedGoogle Scholar
  85. 85.
    Amalric P, Dauban F, Courtois M, Broqua JP. [Clinical symptoms and angiography of retinal artery macro-aneurysms]. Bull Soc Ophthalmol Fr 1979;79:109–111.Google Scholar
  86. 86.
    Townsend-Pico WA, Meyers SM, Lewis H. Indocyanine green angiography in the diagnosis of retinal arterial macroaneurysms associated with submacular and preretinal hemorrhages: a case series. Am J Ophthalmol 2000;129:33–37.PubMedGoogle Scholar
  87. 87.
    Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559–568.PubMedGoogle Scholar
  88. 88.
    Hudomel J, Imre G. Photocoagulation treatment of solitary aneurysm near the macula lutea. Report of a case. Acta Ophthalmol (Copenh) 1973;51:633–638.Google Scholar
  89. 89.
    Stallard HB. Radiant energy as (a) a pathogenic and (b) a therapeutic agent in ophthalmic disorders. Br J Ophthalmol Suppl 1933;6:1–126.Google Scholar
  90. 90.
    Kinyoun JL, Lawrence BS, Barlow WE. Proliferative radiation retinopathy. Arch Ophthalmol 1996;114:1097–1100.PubMedGoogle Scholar
  91. 91.
    Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. VI. X-ray irradiation, carotid artery occlusion, collagen vascular disease, and vitreitis. Arch Ophthalmol 1968;80:606–617.PubMedGoogle Scholar
  92. 92.
    Amoaku WM, Lafaut B, Sallet G, De Laey JJ. Radiation choroidal vasculopathy: an indocyanine green angiography study. Eye 1995;9(pt 6):738–744.PubMedGoogle Scholar
  93. 93.
    Sutter FK, Gillies MC. Intravitreal triamcinolone for radiationinduced macular edema. Arch Ophthalmol 2003;121:1491–1493.PubMedGoogle Scholar
  94. 94.
    Thorne JE, Maguire AM. Good visual outcome following laser therapy for proliferative radiation retinopathy. Arch Ophthalmol 1999;117:125–126.PubMedGoogle Scholar
  95. 95.
    Coats G. Forms of retinal disease with massive exudation. R London Ophthalmol Hosp Rep 1908;17:440–459.Google Scholar
  96. 96.
    Egerer I, Tasman W, Tomer TT. Coats disease. Arch Ophthalmol 1974;92:109–112.PubMedGoogle Scholar
  97. 97.
    Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol 2001;131:572–583.PubMedGoogle Scholar
  98. 98.
    Kranias G, Krebs TP. Advanced Coats’ disease successfully managed with vitreo-retinal surgery. Eye 2002;16:500–501.PubMedGoogle Scholar
  99. 99.
    Kreusel KM, Krause L, Broskamp G, Jandeck C, Foerster MH. Pars plana vitrectomy and endocryocoagulation for paracentral Coats’ disease. Retina 2001;21:270–271.PubMedGoogle Scholar
  100. 100.
    Engelbrecht NE, Aaberg TM Jr, Sung J, Lewis ML. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol 2002;120:320–324.PubMedGoogle Scholar
  101. 101.
    Chew EY, Murphy RP, Newsome DA, Fine SL. Parafoveal telangiectasis and diabetic retinopathy. Arch Ophthalmol 1986;104:71–75.PubMedGoogle Scholar
  102. 102.
    Mansour AM, Schachat A. Foveal avascular zone in idiopathic juxtafoveolar telangiectasia. Ophthalmologica 1993;207:9–12.PubMedGoogle Scholar
  103. 103.
    Berger AS, McCuen BW II, Brown GC, Brownlow RL Jr. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 1997;17:94–98.PubMedGoogle Scholar
  104. 104.
    Alldredge CD, Garretson BR. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 2003;23:113–116.PubMedGoogle Scholar
  105. 105.
    Condon PI, Serjeant GR. Ocular findings in sickle cell thalassemia in Jamaica. Am J Ophthalmol 1972;74:1105–1109.PubMedGoogle Scholar
  106. 106.
    Gagliano DA, Goldberg MF. The evolution of salmon-patch hemorrhages in sickle cell retinopathy. Arch Ophthalmol 1989;107:1814–1815.PubMedGoogle Scholar
  107. 107.
    Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol 1971;71:649–665.PubMedGoogle Scholar
  108. 108.
    Jacobson MS, Gagliano DA, Cohen SB, et al. A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. Ophthalmology 1991;98:581–585.PubMedGoogle Scholar
  109. 109.
    Lee CB, Woolf MB, Galinos SO, Goldbaum MH, Stevens TS, Goldberg ME Cryotherapy of proliferative sickle retinopathy. Part I. Single freeze-thaw cycle. Ann Ophthalmol 1975;7:1299–1308.PubMedGoogle Scholar
  110. 110.
    Eales H. Cases of retinal hemorrhage associated with epistaxis and constipation. Birmingham Med Rev 1880;9:262.Google Scholar
  111. 111.
    Madhavan HN, Therese KL, Doraiswamy K. Further investigations on the association of Mycobacterium tuberculosis with Eales’ disease. Indian J Ophthalmol 2002;50:35–39.PubMedGoogle Scholar
  112. 112.
    Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales disease—an update. Surv Ophthalmol 2002;47:197–214.PubMedGoogle Scholar
  113. 113.
    Atmaca LS, Gunduz K, Idil A. Photocoagulation in Eales disease. Ocul Immunol Inflamm 1993;l:49–54.Google Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Lihteh Wu
    • 1
  • Andrea Porras
    • 2
  • Raquel Benavides
    • 2
  • David G. Zeballos
    • 3
  • J. Fernando Arevalo
    • 3
  1. 1.Retina ServiceInstituto de Cirugia OcularSan JoseCosta Rica
  2. 2.Department of OphthalmologyHospital MexicoSan Jose
  3. 3.Retina and Vitreous Service, Clinica Oftalmológica Centro CaracasArevalo-Coutinho Foundation for Research in OphthalmologyCaracasVenezuela

Personalised recommendations